Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
OBJECTIVES: To perform a literature review and develop recommendations for the use of rituximab in ANCA-associated vasculitis. METHODS: A committee of experts (five rheumatologists, five nephrologists and one paediatrician) conducted a modified Delphi exercise to identify five topics for a systemat...
Main Authors: | Guerry, M, Brogan, P, Bruce, I, D'Cruz, D, Harper, L, Luqmani, R, Pusey, C, Salama, A, Scott, D, Savage, C, Watts, R, Jayne, DR |
---|---|
格式: | Journal article |
語言: | English |
出版: |
2012
|
相似書籍
-
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
由: Flossmann, O, et al.
出版: (2006) -
Anti-neutrophil cytoplasmic antibody associated vasculitis following rituximab: Outcomes of 50 patients in a tertiary single centre
由: Fahidah Alenzi, et al.
出版: (2023-09-01) -
Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.
由: Latimer, N, et al.
出版: (2014) -
Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
由: Latimer, N, et al.
出版: (2014) -
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
由: Hellmich, B, et al.
出版: (2007)